Bevacizumab for Metastatic Colorectal Cancer: A Global Cost‐Effectiveness Analysis

Oncologist - United States
doi 10.1634/theoncologist.2016-0455
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

PCN22 Safety Profile of Bevacizumab in Metastatic Colorectal Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Effect of Application and Intensity of Bevacizumab-Based Maintenance After Induction Chemotherapy With Bevacizumab for Metastatic Colorectal Cancer: A Meta-Analysis

Clinical Colorectal Cancer
OncologyGastroenterology
2016English

Selective Internal Radiotherapy (SIRT) Using Resin Yttrium-90 Microspheres for Chemotherapy-Refractory Metastatic Colorectal Cancer: A UK Cost-Effectiveness Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Cost Effectiveness of Trifluridine/Tipiracil for Previously Treated Metastatic Colorectal Cancer in England and Wales

Clinical Colorectal Cancer
OncologyGastroenterology
2018English

Bevacizumab Improves Survival in Metastatic Colorectal Cancer Patients With Primary Tumor Resection: A Meta-Analysis

Scientific Reports
Multidisciplinary
2019English

HER-2 Testing and Trastuzumab Therapy for Metastatic Breast Cancer: A Cost-Effectiveness Analysis

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2004English

Colorectal Cancer Screening Based on Age and Gender: A Cost-Effectiveness Analysis

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2015English

The Clinical Benefit of Bevacizumab in Metastatic Colorectal Cancer Is Independent of K-Ras Mutation Status: Analysis of a Phase III Study of Bevacizumab With Chemotherapy in Previously Untreated Metastatic Colorectal Cancer

Oncologist
Cancer ResearchMedicineOncology
2009English

Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination With Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis

BioDrugs
MedicineBiotechnologyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy